相关实验视频

Updated: Jul 16, 2025

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

[¹⁸F]SDM-4MP3的首次人类PET成像:一个警告故事

Kimberly L Desmond^1,2, Anton Lindberg¹, Armando Garcia¹

¹Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.

Molecular imaging

|September 18, 2023

概括

调查[18F]SynVesT-1 PET放射性药物发现了一个意想不到的前体衍生物. 这导致了首次对[18F]SDM-4MP3进行人体研究,这种变体不适合用于突触囊泡蛋白2A成像.

科学领域:

神经科学是一个神经科学.
放射化学放射化学是指辐射化学.
核医学就是核医学.

背景情况:

突触囊泡蛋白2A (SV2A) PET成像对于评估神经和精神疾病中的突触密度至关重要.
[18F]SynVesT-1被开发为一种针对SV2A.的PET放射性药物.
使用[18F]SynVesT-1对人类PET的初步研究产生了异常的生物分布数据.

研究的目的:

调查早期[18F]SynVesT-1 PET研究中观察到的异常生物分布的原因.
报告调查结果和对结构变异的首次人体研究, [18F]SDM-4MP3.

主要方法:

同时使用[18F]SynVesT-1进行PET成像研究.
在老鼠身上进行动物成像研究.
质子和碳2D-NMR光谱分析.
对从制造商那里获得的前体材料进行调查.

主要成果:

在人类PET研究中异常生物分布,尽管符合质量控制标准.
发现了由制造商提供的前体材料的衍生物.
[18F]SDM-4MP3,是[18F]SynVesT-1的结构变体,被确定并研究.
[18F]SDM-4MP3缺乏有效的SV2A PET成像中枢神经系统所需的特性.

结论:

前体衍生物导致[18F]SynVesT-1.的异常结果.
[18F]SDM-4MP3不适合作为PET放射性药物用于成像SV2A.
前体材料的质量控制对于放射性药物开发和临床应用至关重要.

更多相关视频

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...